Related Experiment Video

Updated: Sep 20, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
04:56

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence

Published on: December 30, 2025

Small molecules that reactivate mutant p53

V J N Bykov1, G Selivanova, K G Wiman

  • 1Department of Oncology-Pathology, Cancer Center Karolinska, SE-171 76 Stockholm, Sweden.

European Journal of Cancer (Oxford, England : 1990)
|August 23, 2003
PubMed

Insights

Mutant p53 proteins are found in half of human tumors, enabling cancer cell survival. Small molecules that restore wild-type p53 function show promise for developing new anticancer drugs.

Area of Science:

  • Oncology
  • Molecular Biology
  • Drug Discovery

Background:

  • Approximately 50% of human tumors harbor mutations in the p53 tumor suppressor gene.
  • Mutant p53 proteins facilitate tumor cell evasion of apoptosis and cell cycle arrest.
  • Elevated expression of mutant p53 is a common feature in many cancers.

Purpose of the Study:

  • To explore the therapeutic potential of restoring wild-type p53 function in cancer.
  • To identify small molecules capable of reactivating mutant p53.
  • To investigate novel strategies for cancer treatment targeting the p53 pathway.

Main Methods:

  • Identification and characterization of small molecules targeting mutant p53.
  • Assays to evaluate the restoration of wild-type p53 conformation and function.
  • Assessment of apoptosis induction in tumor cells expressing mutant p53.

Main Results:

  • Several classes of small molecules have been identified that can revert mutant p53 to its wild-type conformation.
  • These molecules effectively restore the tumor-suppressive functions of p53.
  • Restoration of wild-type p53 function leads to significant apoptosis in tumor cells.

Conclusions:

  • Targeting mutant p53 with small molecules represents a promising therapeutic strategy for cancer.
  • Restoring wild-type p53 function can induce tumor-specific cell death.
  • These findings provide a foundation for developing novel anticancer drugs based on p53 reactivation.

More Related Videos

Yeast As a Chassis for Developing Functional Assays to Study Human P5314:57

Yeast As a Chassis for Developing Functional Assays to Study Human P53

Published on: August 4, 2019

Purification of Ubiquitinated p53 Proteins from Mammalian Cells10:55

Purification of Ubiquitinated p53 Proteins from Mammalian Cells

Published on: March 21, 2022

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Covalently Linked Protein Regulators02:04

Covalently Linked Protein Regulators

Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein.
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.